Valuation for Lexaria Bioscience Corp. (id:6130 LEXX)
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|---|---|---|
| Trailing P/E | -2.06 |
|
|
| Forward P/E | -5.79 |
|
|
| Price to sales | 99.36 |
|
|
| Price to book | 3.53 |
|
|
| Enterprise to revenue | 60.67 |
|
|
| Enterprise to ebitda | -5.50 |
|
|